|
Fusion gene ID: 9693 |
FusionGeneSummary for DEFA1_RNF115 |
Fusion gene summary |
Fusion gene information | Fusion gene name: DEFA1_RNF115 | Fusion gene ID: 9693 | Hgene | Tgene | Gene symbol | DEFA1 | RNF115 | Gene ID | 1667 | 27246 |
Gene name | defensin alpha 1 | ring finger protein 115 | |
Synonyms | DEF1|DEFA2|HNP-1|HP-1|HP1|MRS | BCA2|ZNF364 | |
Cytomap | 8p23.1 | 1q21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | neutrophil defensin 1defensin, alpha 1, myeloid-related sequencedefensin, alpha 2myeloid-related sequence | E3 ubiquitin-protein ligase RNF115RING-type E3 ubiquitin transferase RNF115rabring 7zinc finger protein 364 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P59665 | Q9Y4L5 | |
Ensembl transtripts involved in fusion gene | ENST00000382679, ENST00000382692, | ENST00000369291, | |
Fusion gene scores | * DoF score | 3 X 3 X 1=9 | 4 X 3 X 3=36 |
# samples | 3 | 5 | |
** MAII score | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(5/36*10)=0.473931188332412 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: DEFA1 [Title/Abstract] AND RNF115 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | DEFA1 | GO:0002227 | innate immune response in mucosa | 12860195 |
Hgene | DEFA1 | GO:0010818 | T cell chemotaxis | 17088326 |
Hgene | DEFA1 | GO:0019731 | antibacterial humoral response | 12860195 |
Hgene | DEFA1 | GO:0030520 | intracellular estrogen receptor signaling pathway | 21861873 |
Hgene | DEFA1 | GO:0031640 | killing of cells of other organism | 17088326 |
Hgene | DEFA1 | GO:0044657 | pore formation in membrane of other organism during symbiotic interaction | 17635867 |
Hgene | DEFA1 | GO:0050830 | defense response to Gram-positive bacterium | 12860195 |
Hgene | DEFA1 | GO:0051852 | disruption by host of symbiont cells | 17635867 |
Hgene | DEFA1 | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 12860195 |
Tgene | RNF115 | GO:0051865 | protein autoubiquitination | 16288031 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AF119902 | DEFA1 | chr8 | 6835175 | - | RNF115 | chr1 | 145635284 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000382679 | ENST00000369291 | DEFA1 | chr8 | 6835175 | - | RNF115 | chr1 | 145635284 | - |
5CDS-intron | ENST00000382692 | ENST00000369291 | DEFA1 | chr8 | 6835175 | - | RNF115 | chr1 | 145635284 | - |
Top |
FusionProtFeatures for DEFA1_RNF115 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
DEFA1 | RNF115 |
Defensin 1 and defensin 2 have antibacterial, fungicideand antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to killmicrobes by permeabilizing their plasma membrane.{ECO:0000269|PubMed:15616305, ECO:0000269|PubMed:17452329}. | E3 ubiquitin-protein ligase that mediates E2-dependent,'Lys-48'- and/or 'Lys-63'-linked polyubiquitination of substratesand may play a role in diverse biological processes. Through theirpolyubiquitination, may play a role in the endosomal traffickingand degradation of membrane receptors including EGFR, FLT3, METand CXCR4. {ECO:0000269|PubMed:16288031,ECO:0000269|PubMed:18819927, ECO:0000303|PubMed:23418353}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for DEFA1_RNF115 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for DEFA1_RNF115 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for DEFA1_RNF115 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for DEFA1_RNF115 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | RNF115 | C1458155 | Mammary Neoplasms | 1 | CTD_human |